TETRAPHASE PHARMACEUTICALS INC 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Feb 1, 2017
Insider Transaction Report
Form 4
Dumas Jacques
Chief ScientificOfficer
Transactions
- Award
Restricted Stock Unit
2017-01-31+30,000→ 30,000 total→ Common Stock (30,000 underlying) - Award
Employee Stock Option (Right to Buy)
2017-01-30+140,000→ 140,000 totalExercise: $3.69Exp: 2027-01-29→ Common Stock (140,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F2]These restricted stock units shall be eligible to vest upon achievement of certain performance conditions and, if such conditions are met, shall vest on January 31, 2020.
- [F3]Vests as to 6.25% of the shares on 4/30/2017 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/30/2021.